Alzheimer's disease
As a 67-year-old individual, facing the diagnosis of Alzheimer's disease in loved ones can be daunting. The fear of succumbing to the same condition is overwhelming, prompting questions about the best course of action. For Fearful, who is visiting his 92-year-old mother in a care home, the pain
Alzheimer's disease
Neuroscientist Dr Cara Croft and her team at the Blizard Institute, Queen Mary University of London, are working tirelessly to find effective treatments for dementia. With funding from the Alzheimer's Society, they are testing ten drugs that could potentially lead to a cure for the disease. Their groundbreaking
Alzheimer's disease
Investigators at Xi' An International Medical Center Hospital in Shanxi, People's Republic of China, have made groundbreaking discoveries in the fight against Alzheimer's disease. Their research, published in the European Journal of Medical Research, reveals that remimazolam (RMZ), a novel ultra-short-acting benzodiazepine, exhibits neuroprotective effects
Alzheimer's disease
Researchers at Universita Campus Bio-Medico di Roma have discussed new findings in the treatment of Alzheimer's disease, highlighting the potential of microfluidic-based technologies in crossing the blood-brain barrier to deliver targeted therapies. The study, published in the International Journal of Molecular Sciences, reveals the advantages of microfluidic platforms
Alzheimer's disease
New research conducted by the Norwegian University of Science and Technology (NTNU) has shed light on the relationship between ITPR1 autoantibody-associated autoimmunity and Alzheimer's disease-like symptoms. The study involved a 58-year-old patient who was admitted with acute confusion, rapidly progressive cognitive decline, and hallucinations, which were initially suggestive
Alzheimer's disease
A groundbreaking study published in Biochimica et Biophysica Acta has found that environmental factors can shape transcriptome signatures related to inflammation and immune pathways, ultimately contributing to Alzheimer's disease development. The research, conducted by a team at the Brain Science Institute in Korea, analyzed the transcriptome of monozygotic
Alzheimer's disease
Researchers from the University of Virginia have made a groundbreaking discovery that sheds new light on the complexities of Alzheimer's disease. Their study, published in the journal Cells, reveals that a newly described form of cell death known as erebosis may occur in the brain, particularly in neurons,
Alzheimer's disease
Researchers from the Department of Computer Science have made a groundbreaking discovery in the field of Alzheimer's disease prediction using the Internet of Medical Things (IoMT). The study proposes an IoMT-driven Alzheimer's prediction framework that combines transfer learning with explainable AI, achieving 97.77% accuracy and
Alzheimer's disease
Recent research conducted by the University of Oslo, Norway, has shed new light on the relationship between sex differences in brain aging and Alzheimer's disease prevalence in women. The study, which utilized longitudinal brain magnetic resonance imaging (MRI) data from 4,726 participants aged 17 to 95, found
Alzheimer's disease
A recent study published in the Annals of Indian Academy of Neurology highlights the need for affordable and scalable biomarkers to enable early and accurate diagnosis and intervention for Alzheimer's disease. The research emphasizes the limitations of current disease-modifying therapies, particularly in low- and middle-income countries, and explores
Advertising executives
Recent research from the National Center for Geriatrics and Gerontology in Aichi, Japan, has identified two new phospho-tau biomarkers, p-tau217 and p-tau181, which show promise in detecting Alzheimer's disease (AD) in its preclinical stages. The study, published in Cell Reports, found that p-tau217 is a sensitive plasma biomarker
Alzheimer's disease
Recent research conducted by the University of Oslo, Norway, has shed new light on the relationship between sex differences in brain aging and Alzheimer's disease prevalence in women. The study, which utilized longitudinal brain magnetic resonance imaging (MRI) data from 4,726 participants aged 17 to 95, found
